Compare DH & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DH | NVX |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Machinery/Components |
| Sector | Technology | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 283.1M | 235.2M |
| IPO Year | 2021 | N/A |
| Metric | DH | NVX |
|---|---|---|
| Price | $2.46 | $1.11 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $4.04 | N/A |
| AVG Volume (30 Days) | 455.1K | ★ 1.6M |
| Earning Date | 02-26-2026 | 01-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $242,275,000.00 | $5,931,433.00 |
| Revenue This Year | N/A | $165.90 |
| Revenue Next Year | N/A | $1,344.85 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.15 | $0.81 |
| 52 Week High | $5.68 | $3.86 |
| Indicator | DH | NVX |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 43.76 |
| Support Level | $2.26 | $1.02 |
| Resistance Level | $2.58 | $1.15 |
| Average True Range (ATR) | 0.12 | 0.10 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 46.86 | 15.00 |
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.